logo
Twitter
Discord
Email
logo
Cross Country Healthcare, Inc.

Cross Country Healthcare, Inc.

NASDAQ•CCRN
CEO: Mr. Kevin Cronin Clark
Sector: Healthcare
Industry: Medical - Care Facilities
Listing Date: 2001-10-25
Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services. It also offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, VMS, in- home care, education healthcare, RPO, project management, and other outsourcing and consultative services. This segment provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. It serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. Its Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand on temporary assignments. It serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
Contact Information
6551 Park of Commerce Boulevard, N.W., Boca Raton, FL, 33487, United States
561-998-2232
www.crosscountry.com
Market Cap
$300.08M
P/E (TTM)
-19.0
29.3
Dividend Yield
--
52W High
$18.30
52W Low
$7.43
52W Range
16%
Rank38Top 36.9%
4.3
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 4.3 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q3 2025 Data

Revenue

$250.05M-20.65%
4-Quarter Trend

EPS

-$0.15-293.80%
4-Quarter Trend

FCF

$17.92M+182.43%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Q3 Revenue Decline Q3 service revenue totaled $250.1M, reflecting a 20.6% decrease compared to $315.1M last year due to volume declines.
Operational Loss Narrowed Nine months loss from operations improved 4.6% to ($12.8M) versus ($13.4M) prior period, showing cost control efforts.
Cash Position Strengthened Cash and equivalents reached $99.1M as of September 30, 2025, up $35.1M year-over-year, supporting liquidity.
Homecare Segment Growth Homecare Staffing segment revenue grew 29.1% year-over-year for the third quarter period, acting as a growth driver.

Risk Factors

Aya Merger Uncertainty Closing contingent on FTC review; termination possible if extension is not agreed upon by the December 3, 2025 deadline.
Staffing Volume Decline Nurse and Allied FTEs decreased 16.8% in Q3 2025, driven by headcount reduction in travel nurse and allied assignments.
Bottom Line Deterioration Q3 net loss was ($4.8M), a significant reversal from $2.6M net income reported in the comparable third quarter of 2024.
Merger Cost Incurred $12.2M in acquisition and integration-related costs recorded for the pending Aya Merger during the nine months ended period.

Outlook

Merger Extension Discussed Management actively discussing extending the Aya Merger end date beyond the current December 3, 2025 termination deadline.
Liquidity Strategy Clear Future cash needs expected to be met by existing cash on hand and revolving credit facility availability for flexibility.
ABL Facility Ready Revolving ABL facility has $121.4M availability with zero borrowings drawn as of September 30, 2025, ensuring access to capital.
Credit Risk Managed Allowance for credit losses stands at $8.8M, reflecting management's assessment of current economic conditions and aging receivables.

Peer Comparison

Revenue (TTM)

Community Health Systems, Inc.CYH
$12.64B
+0.7%
agilon health, inc.AGL
$5.89B
+5.2%
Cross Country Healthcare, Inc.CCRN
$1.13B
-22.1%

Gross Margin (Latest Quarter)

XOMA Royalty CorporationXOMA
90.6%
-9.4pp
OrthoPediatrics Corp.KIDS
73.9%
+0.5pp
Surmodics, Inc.SRDX
71.0%
+1.7pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
SRDX$614.51M-34.8-15.6%19.2%
SNDA$594.43M-12.3-44.1%80.1%
EHAB$533.26M-44.8-2.2%42.0%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-6.9%
Growth Under Pressure
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
100%
Strong Cash Flow

Research & Insights

Next earnings:Mar 4, 2026
|
EPS:$0.03
|
Revenue:-
Reports
All Years
  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Nov 12, 2025|
    Revenue: $250.05M-20.6%
    |
    EPS: $-0.15-293.8%
    Miss
  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Aug 6, 2025|
    Revenue: $274.07M-19.3%
    |
    EPS: $-0.20-57.4%
    Miss
  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 7, 2025|
    Revenue: $293.41M-22.6%
    |
    EPS: $-0.02-125.4%
    Miss
  • Form 10-K/A - FY 2024

    Period End: Dec 31, 2024|Filed: Apr 16, 2025|
    Revenue: $1.34B-33.5%
    |
    EPS: $-0.44-121.3%
    Miss
  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Mar 5, 2025|Refer to amended data
  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 7, 2024|
    Revenue: $315.12M-28.8%
    |
    EPS: $0.08-79.1%
    Miss
  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 1, 2024|
    Revenue: $339.77M-37.2%
    |
    EPS: $-0.47-178.3%
    Miss
  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 2, 2024|
    Revenue: $379.17M-39.1%
    |
    EPS: $0.08-90.4%
    Miss